Community Funding Opportunities

Due Date: 01-09-2017
The purpose of this FOA is to encourage innovative exploratory and developmental health services research to improve minority health and/or reduce health disparities at the health care system-level as well as within clinical settings. R01 also available

Due Date: 07-26-2018
This fine-year initiative is to improve health, prevent chronic diseases, and reduce health disparities among racial and ethnic populations with the highest risk, or burden, of chronic disease, specifically for African Americans, Hispanic Americans, Asian Americans, Native Hawaiian/Other Pacific Islanders, American Indians, and Alaska Natives.

Due Date: 07-23-2018
The Health Resources and Services Administration¿s Federal Office of Rural Health Policy plans to award up to 75 grants to rural communities as part of a new Rural Communities Opioid Response Planning initiative in FY 18. Successful awardees will receive up to $200,000 for one-year to develop plans to implement opioid use disorder prevention, treatment, and recovery interventions designed to reduce opioid overdoses among rural populations.

Due Date: 06-28-2018
The Centers for Medicare & Medicaid Services (CMS) Office of Minority Health (OMH) is announcing the availability of funds under the Minority Research Grant Program to test promising solutions that close gaps in disparities research. The purpose of the program is to support researchers investigating systems-level solutions to social determinants of health issues that affect patient experiences and readmissions and ultimately health outcomes.

Due Date: 06-29-2018
The foundation is committed to assisting in impact areas focusing on education, human services and health-related causes around the country.

Due Date: 07-02-2018
The GGACT cooperative, a collaboration between Boston Children¿s Hospital, Cincinnati Children¿s Hospital Medical Center, and the University of California Los Angeles, was established to support investigators in rapidly translating complex gene and cell therapies to early phase, investigator-initiated clinical trials by providing expertise in protocol development and implementation, trial and data management, and regulatory affairs, as well as utilizing established infrastructure for preclinical models of disease and testing, process development, and GMP vector production and cellular manufacturing. Eligible applicants must be faculty at a CTSA institution that has an established pediatric stem cell transplant program.

Due Date: 07-05-2018
The Administration for Children and Families, Administration on Children, Youth and Families' Family and Youth Services Bureau announces the availability of funds. The program works to establish or strengthen community-based programs that meet the immediate needs of runaway and homeless youth up to age 18 years of age and their families.

Due Date: 07-06-2018
Supports the next generation of creative thinkers with ¿high-risk/high-reward¿ ideas for prevention, diagnosis, or treatment of cancer.

Due Date: 07-13-2018
The American Heart Association and the Robert Wood Johnson Foundation are working to create a culture of health with the Voices for Healthy Kids initiative. Through this collaboration, and in partnership with a team of experts across the healthy eating and active living movement, the initiative aims to engage, organize, and mobilize people to help all children grow up at a healthy weight.

Due Date: 07-15-2018
Prize for young scientists for outstanding life science research.

Due Date: 06-15-2018
This program provides affordable funding to develop essential community facilities in rural areas. An essential community facility is defined as a facility that provides an essential service to the local community for the orderly development of the community in a primarily rural area, and does not include private, commercial, or business undertakings.

Due Date: 11-16-2017
The fund provides low-interest loans to low-income rural communities for predevelopment costs, system upgrades, and new construction of water and wastewater services and facilities. Loans are also available for housing and community development.

The money will be deployed by the NoVo Foundation via three streams to fund: 1) community-based organizations¿ budget line items on continuing operations; 2) organizations and efforts in the southeastern U.S. in concert with a yet-undetermined regional partner. This money will also be used to form new organizations necessary to affect change and to fund individual efforts that may exist outside of established organizations; 3) broader concerns on a national level, including research organizations and policy change measures.

The Avon Breast Health Outreach Program (BHOP) provides grants to nonprofit organizations to conduct outreach, provide education on breast health and breast cancer screening, link medically underserved women to care providers and clinical screening services, and help navigate patients through any necessary follow-up care.

Discovery Funding Opportunities

Due Date: 07-26-2018
The purpose of the grant is to support high quality conferences that are relevant to the public health and to the scientific mission of the participating Institutes and Centers.

Due Date: 07-07-2018
This FOA calls for research grant applications that address patient adherence to treatment and prevention regimens to promote health outcomes.

Due Date: 06-19-2018
This FOA represents the continuation of an NCI program to enhance the diversity of the pool of the cancer research workforce by recruiting and supporting eligible junior investigators and Early Stage Investigators from groups that have been shown to be nationally underrepresented in the biomedical, behavioral, clinical, and social sciences. This opportunity will also provide a bridge to investigators who have completed their research training and may need extra time to develop a larger research project grant application.

Due Date: 06-20-2018
This STI CRC program will facilitate multidisciplinary, synergistic collaborations to support the development of vaccines to control and prevent sexually transmitted infections (STIs) caused by the following pathogens, which have limited candidates in the product development pipeline: Neisseria gonorrhoeae, Chlamydia trachomatis, and Treponema pallidum.

Due Date: 06-11-2018
The Creative Promise Prizes were established in 2009 to honor emerging immigrant professionals who have demonstrated significant accomplishments early in their careers.

Due Date: 06-11-2018
This FOA seeks applications for the design and development of technologies to monitor health or deliver care in a real-time, accessible, effective, and minimally obtrusive way for older adults with a chronic heart, lung, blood, or sleep condition.

Due Date: 06-11-2018
This FOA seeks applications for the design and development of technologies to monitor health or deliver care in a real-time, accessible, effective, and minimally obtrusive way for older adults with a chronic heart, lung, blood, or sleep (HLBS) condition. These technologies may be novel sensor or monitoring systems, home-use point-of-care devices, home or mobile therapy or rehabilitation tools, or information systems and should have the goal of fostering healthy and independent living for aging adults with HLBS conditions.

Due Date: 06-14-2018
This FOA seeks applications that propose to develop and test T4 implementation strategies to identify facilitators and overcome barriers in the adaptation, integration, scale-up, and sustainability of proven-effective interventions and guidelines for preventing and/or managing heart, lung, and blood diseases and/or sleep disorders. The proposed implementation strategies must be adaptable and responsive to community needs and contexts, and must account for cultural and organizational factors.

Due Date: 06-20-2018
The RIVER program seeks to provide support for the majority of the independent research program for outstanding investigators in the Environmental Health Sciences, giving them intellectual and administrative freedom, as well as sustained support to pursue their research in novel directions in order to achieve greater impacts.

Due Date: 06-20-2018
The award is intended to support the research and research career advancement of outstanding, exceptionally productive scientists who are in the early, formative stages of their careers, and who plan to make a long-term career commitment to research in specific mission areas of the NIMH. This award seeks to assist these individuals in launching an innovative clinical, translational, basic or services research program that holds the potential to profoundly transform the understanding, diagnosis, treatment, or prevention of mental disorders.

Due Date: 06-21-2018
This FOA will support innovative research projects that are focused on image-guided drug delivery, including real-time image guidance, monitoring, quantitative in vivo characterizations and validation of delivery and response. It will support research in development of integrated imaging-based systems for delivery of drugs or biologics in cancer and other diseases, quantitative imaging assays of drug delivery, and early intervention.

Due Date: 06-22-2018
The ACE program, a cooperative network intended to improve the understanding, prevention, and treatment of autoimmune diseases, was founded on the premise that collaborations among basic and clinical scientists can accelerate both fundamental and applied research.

Due Date: 06-22-2018
The Bill and Melinda Gates Foundation seeks proposals that engage scientists across a variety of disciplines, including those new to the influenza field, demonstrate innovative thinking by incorporating concepts or technologies not currently being used within/addressed by the influenza vaccine field, present concepts and strategies that are off the beaten track, significantly radical in conception, and daring in premise.

Due Date: 06-25-2018
FDA seeks to support the application of novel technologies for advanced manufacturing of complex biologic products, and innovative analytical approaches to improve product manufacturing and quality through active research.

Due Date: 06-29-2018
The Veterans Integrated Service Network (VISN) 7 announces a Research Development Award, which will fund 5/8 support for up to two years and is open to early stage investigators (within 5 years of terminal degree) or VA clinicians seeking a career change or research topic change. A total of four awards will be funded across VISN 7 (includes Alabama, Georgia and South Carolina).

Due Date: 06-25-2018
This FOA is issued by the NIH Adherence Network through the OBSSR with participation from multiple NIH Institutes and Centers. This FOA calls for research grant applications that address patient adherence to treatment and prevention regimens to promote health outcomes. Applications may address healthcare regimen initiation, implementation, and/or persistence by patients.

Due Date: 06-25-2018
This FOA invites research projects to improve understanding of the causes of high priority diseases in the U.S. and reducing/eliminating health disparities. Research is encouraged in the following high priority diseases within the scientific mission areas of the NIDDK: diabetes; obesity; nutrition-related disorders; hepatitis C; gallbladder disease; H. Pylori infection; sickle cell disease, specifically, studies in complications of sickle cell disease within the NIDDK mission areas; kidney diseases; urologic diseases; hematologic diseases, including studies in abnormal hemoglobin synthesis; metabolic diseases; gastrointestinal, hepatic, and renal complications from infection with HIV.

Due Date: 06-29-2018
For the purpose of this FOA, reproductive health includes both fertility/infertility and gynecological health. These centers provide an arena for multidisciplinary interactions among basic and clinical scientists interested in establishing high quality translational research programs in these scientific areas.

Due Date: 07-02-2018
This Pathway to Stop Diabetes initiative accepts nominations for exceptional investigators with medical and scientific backgrounds who propose innovative basic, clinical, translational, behavioral, epidemiological and health services research relevant to any type of diabetes, diabetes-related disease state or complication.

Due Date: 07-03-2018
This program supports important and innovative research in areas in which more scientific investigation is needed to improve the prevention, diagnosis, treatment, and care for Alzheimer's disease and related dementias. The program seeks (i) to facilitate the next generation of researchers in the United States to pursue research and academic careers in neurosciences, AD/ADRD and healthy brain aging, and (ii) to stimulate established researchers who are not currently doing AD/ADRD research to perform pilot studies toward developing new innovative AD/ADRD research programs that leverage and build upon their existing expertise.

Due Date: 07-06-2018
This announcement seeks proposals from universities to purchase equipment and instrumentation in support of research in areas of interest to the DOD. A central purpose of the program is to provide equipment and instrumentation to enhance research-related education in areas of interest and priority to the DOD.

Due Date: 07-09-2018
The IDG consortium's purpose is to facilitate the unveiling of the functions of selected understudied proteins in the Druggable Genome using experimental and informatics approaches. Currently, this research consortium is composed of multiple Data and Resource Generation Centers (DRGCs), a Knowledge Management Center (KMC), and a Resource Dissemination and Outreach Center (RDOC). The purpose of this specific FOA is to solicit applications to build a set of Cutting Edge Informatics Tools (CEITs) that will augment the capability of the KMC as well as the broader IDG Consortium.

Due Date: 07-10-2018
This opportunity is intended to fund collaborative projects that bring new expertise and innovative approaches to enhance the value of major ongoing clinical research projects.

Due Date: 07-10-2018
This FOA will support research to test approaches in the healthcare setting to using Patient-Reported Outcomes (PROs) as tools to enhance patient-centered treatment and improve outcomes in individuals with type 1 diabetes.

Due Date: 07-10-2018
This FOA seeks applications for clinical trials testing interventions targeting diabetes distress in individuals with T1D and/or their caregivers, with the goal of understanding whether lowering diabetes distress will improve glycemic control and quality of life.

Due Date: 07-10-2018
This FOA encourages applications from institutions/organizations proposing research on the use of current and emerging technologies for monitoring of blood glucose levels to capture the relationship between blood glucose excursions, perception of wellbeing, and cognitive status in people with T1D.

Due Date: 07-10-2018
The proposed assays should be highly reproducible, easily transferable to other laboratories, easy to multiplex, and validated in human plasma or serum.

Due Date: 07-12-2018
The NIH¿s All of Us Research Program issued a funding announcement for genome centers to generate genotype and whole genome sequence data from participants¿ biosamples.

Due Date: 07-13-2018
The purpose of the NINDS Research Program Award (RPA) is to provide longer-term support and increased flexibility to Program Directors/Principal Investigators whose records of research achievement demonstrate their ability to make major contributions to neuroscience.

Due Date: 07-19-2018
The purpose of this FOA is to provide support for planning activities for late phase (phase II and beyond) single-site or multi-site investigator-initiated clinical trials that address critical clinical questions within the mission of the National Heart, Lung, and Blood Institute (NHLBI) and that require non-traditional clinical trial designs with the opportunity for statistical novelty and/or innovation.

Due Date: 07-19-2018
The purpose of this FOA is to provide support for planning activities for late phase (phase II and beyond) single-site or multi-site investigator-initiated clinical trials that address critical clinical questions within the mission of the National Heart, Lung, and Blood Institute (NHLBI) and that require non-traditional clinical trial designs with the opportunity for statistical novelty and/or innovation. The FOA will support the development of feasible and well-designed clinical trials utilizing consultative services provided by the Innovative Clinical Trials Resource (ICTR) (N01).

Due Date: 07-24-2018
This FOA encourages collaborative teams to target gaps in methods and outcomes regarding research participant recruitment and retention.

Due Date: 07-24-2018
To be eligible for this PFA, applicants may either a) propose to implement a shared decision making (SDM) strategy that was formally tested and demonstrated to be effective in the context of a PCORI research award, or b) propose an implementation project that will incorporate new PCORI CER evidence into an existing, tested shared decision making strategy, and then implement the updated shared decision making strategy.

Due Date: 07-25-2018
The purpose of this award is to support outstanding basic and/or clinical researchers with the vision and expertise to translate research discoveries into medications for the treatment of Substance Use Disorders (SUDs) stemming from tobacco, cannabis, cocaine, methamphetamine, heroin, or prescription opiate use.

Due Date: 08-06-2018
The Beckman Young Investigator (BYI) Program provides research support to the most promising young faculty members in the early stages of their academic careers in the chemical and life sciences, particularly to foster the invention of methods, instruments and materials that will open up new avenues of research in science.

Due Date: 08-31-2018
The goal of the Informatics Research Starter Grants program is to promote development and use of novel informatics in an integrative approach toward understanding normal processes of human biology and disease processes. The awards offer financial support to individuals beginning independent research careers in pharmaceutics (including basic pharmaceutics, biopharmaceutics, pharmaceutical technology, and pharmaceutical biotechnology) at the faculty level.

Due Date: 08-13-2018
The Research Project Grant (R01) is an award made by AHRQ to an institution/organization to support a discrete, specified health services research project. The R03 grant mechanism supports different types of health services research projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The health services research demonstration and dissemination grants (R18) is made to an institution or organization to support a discrete, specified health services research project.

Due Date: 09-10-2018
Supports exceptionally creative early career scientists proposing innovative and high-impact projects. The NIH definition of an Early Stage Investigator now includes clinical training.

Due Date: 09-14-2018
The program provides unique opportunities for exceptionally creative scientists to pursue highly innovative approaches to address major challenges in biomedical or behavioral research. Any research topic relevant to the broad mission of NIH is welcome. NIH especially encourages women and members of groups that are underrepresented in NIH-funded research to apply.

Due Date: 09-18-2018
Deprescribing, the cessation of long-term therapy under clinician supervision, is a fundamental technique of geriatric practice and palliative medicine to address inappropriate medication use and/or polypharmacy common among older adults with multimorbidity.

Due Date: 09-21-2018
Supports individuals or teams proposing projects that are inherently risky and untested but have the potential to create or overturn fundamental paradigms.

Due Date: 09-28-2018
The American Heart Association/American Stroke Association (AHA/ASA) greatly value the development of Young Investigators and Early Career Professionals and therefore, provide funded Investigator-led Research opportunities through a limited number of Young Investigator Database Research Seed Grants using data from AHA/ASA Quality Improvement Programs, including Get With The Guidelines.

Due Date: 11-30-2018
The National Blood Foundation awards grants for investigator-initiated original research in all aspects of blood banking, transfusion medicine, cellular therapies and patient blood management.

Due Date: 12-06-2018
This FOA encourages applications from integrative teams and individual investigators for projects to determine the mechanisms underlying the contribution of these risk-associated genes and their variants for Type 1 Diabetes (T1D). The purpose is to accelerate the discovery of function of the causal genes and variants that influence the risk for disease.

Due Date: 12-06-2018
Understanding Skeletal Effects of Type 1 Diabetes (R01 Clinical Trial Optional)

Due Date: 07-23-2018
To give research teams extra time to consider their applications, PCORI posted five research funding preannouncements. Two preannouncements describe soon-to-be-reopened funding opportunities; one focuses on medication-assisted treatment delivery for pregnant women with substance use disorders and the other focuses on symptom management for advanced illnesses. A third preannouncement focuses on addressing health disparities and a fourth on improving methods for conducting patient-centered outcomes research. The fifth preannouncement will focus on the implementation of effective shared decision making approaches in healthcare settings.

Due Date: 06-15-2018
The NIH Common Fund has established the Gabriella Miller Kids First Pediatric Research Program (Kids First) to develop a pediatric research data resource populated by genome sequence and phenotype data that will be of high value for the communities of investigators who study the genetics of childhood cancers and/or structural birth defects.

Due Date: 04-09-2018
The CDMRP is providing information to allow investigators time to plan and develop ideas for submission to anticipated FY18 funding opportunities for ALS, MS, breast and ovarian cancers, and bone marrow failure research.

This FOA encourages grant applications that propose adapting adult biomarkers to children. This would include the application and validation of biomarkers developed in adults to pediatric diagnosis, prognosis, and estimation of disease progression, toxicity, and response to therapy.

Due Date: 12-31-2017
NIH is offering funding for administrative supplements to encourage and improve the diversity of the research workforce. This funding can help recruitment efforts and support for students, postdoctorates and eligible investigators from groups that have been underrepresented in health-related research.

Due Date: 12-29-2017
This FOA calls for research on the health of transgender and gender nonconforming people of all ages, who are questioning their gender identity and those individuals who are making or who have made a transition from being identified as one gender to the other. This group encompasses individuals whose gender identity differs from the sex on their original birth certificate or whose gender expression varies significantly from what is traditionally associated with or typical for that sex.

The grant will support research by a junior investigator. Applicants are encouraged to consider using the SGIM Research Dataset Compendium for their proposed research projects. This resource provides information about a number of public use datasets and provides opportunities from investigators to get mentoring and one-time consultation from senior SGIM members who are experienced in accessing and using the datasets.

The objective of the award is to provide support for senior investigators who have the expertise and leadership skills to enhance aging and geriatric research capacity within their academic institution.

This FOA will support small grants on primary immunodeficiency diseases focusing on ex vivo studies with human specimens and on studies with current or new animal models including novel clinical strategies for detecting, identifying the molecular basis of, or developing innovative therapies for primary immunodeficiency diseases.

The NIH Commons Credits Model is a time- and cost-efficient way for NIH-funded biomedical investigators to gain cloud computing support for their current research as well as pave the way toward better accessibility, interoperability, and reuse of digital objects for future research. This is not a grant; this funding is recommended to supplement current NIH grants or to jump start a related grant in the biomedical space.

This FOA encourages exploratory or developmental research grant applications to develop new tools, methods, and models focused on palliative care in geriatric populations. The request for applications covers studies in a variety of healthcare or community settings. R01 and R21 available

Evidence for Action (E4A), a national program of the Robert Wood Johnson Foundation, funds research that expands the evidence base needed to build a Culture of Health. Their mission is to support rigorously designed quantitative, qualitative, and mixed methods research that yields convincing findings regarding the population health, well-being, and equity impacts of specific policies, programs and partnerships.

This FOA invites R01 applications that propose to study the ethical, legal and social implications (ELSI) of human genome research. Proposed approaches may include but are not limited to data-generating qualitative and quantitative approaches, legal, economic and normative analyses, and other types of analytical and conceptual research methodologies, such as those involving the direct engagement of stakeholders.

This FOA encourages applications that propose to conduct secondary analyses of publicly available NICHD-funded data sets or stored biospecimens. The goal of this program is to facilitate innovative yet cost-effective research utilizing data and biospecimens collected with NICHD resources.

The program is designed to develop partnerships between pharmaceutical companies and the biomedical research community to advance therapeutics development. X02, UG3/UH3, and pediatric UG3/UH3 available.

Are you frustrated with a device that you use? Is there a clinical process you see that needs improvement? Do you have a brilliant idea for a system, device, or program that would make life better `For the Kids¿? Quick Wins is a funding program put in place to provide rapid solutions to unmet clinical and business needs at Children¿s Healthcare of Atlanta.

Due Date: 09-27-2018
The NIH Common Fund announces FY 2019 funding opportunity for the NIH Director's Early Independence Awards in the High-Risk, High-Reward Research program. The program provides unique opportunities for exceptionally creative scientists to pursue highly innovative approaches to address major challenges in biomedical or behavioral research.

Training Funding Opportunities

Due Date: 12-04-2017
The initiative will allocate approximately $210 million in FY2017 and an additional $210 million each year for four years to support additional meritorious early-stage and mid-career investigators. This amount will ramp up over five years to reach approximately $1.1 billion per year.

Due Date: 01-15-2018
The award is a three-year bridge scholar development program for newly independent faculty who intend to pursue research careers in environmental health sciences.

Due Date: 01-15-2018
The goal of the program is to develop a diverse pool of well-trained scientists available to address the Nation's biomedical research agenda. Specifically, this FOA provides support to eligible, domestic institutions to develop and implement effective, evidence-based approaches to biomedical graduate training and mentoring that will keep pace with the rapid evolution of the biomedical research enterprise.

Due Date: 01-15-2018
The award is designed to enhance the participation of highly trained early career investigators from underrepresented groups in neuroscience research. This opportunity provides postdoctoral fellows from underrepresented groups with strong training in neuroscience with the resources and tools that will help facilitate a transition to a stable and productive independent research position.

Due Date: 06-28-2018
The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NHLBI R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nation¿s biomedical, behavioral and clinical research needs.

Due Date: 06-29-2018
The over-arching goals of the NIH R25 program are to: (1) complement and/or enhance the training of a workforce to meet the nation's biomedical, behavioral, and clinical research needs; (2) enhance the diversity of the biomedical, behavioral, and clinical research workforce; (3) help recruit individuals with specific specialty or disciplinary backgrounds to research careers in biomedical, behavioral, and clinical sciences; and (4) foster a better understanding of biomedical, behavioral, and clinical research and its implications.

Due Date: 07-15-2018
The program seeks to stimulate fundamental research by early-career scientists and scholars of outstanding promise. Successful candidates generally have a strong record of significant independent research accomplishments that demonstrate creativity and the potential to become future leaders in the scientific community. Fellowships are awarded in the following categories Chemistry, Computational & Evolutionary Molecular Biology, Computer Science, Economics, Mathematics, Neuroscience, Ocean Sciences, and Physics.

Due Date: 09-04-2018
The purpose of this FOA is to enhance the participation of individuals from nationally underrepresented backgrounds in cardiovascular, pulmonary, hematologic and sleep disorders research across the career development continuum by providing support to institutions that promote diversity.

Due Date: 08-31-2018
This FOA encourages applications for the Lasker Clinical Research Scholars Program for the purpose of supporting the research activities during the early stage careers of independent clinical researchers. The program offers the opportunity for a unique bridge between the NIH intramural and extramural research communities and contains two phases.

Due Date: 09-07-2018
The objective of the award is to support young gastroenterologists working toward independent and productive research careers in digestive diseases by ensuring that a major proportion of their time is protected for research.

Due Date: 09-10-2018
The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NHLBI R25 program is to support educational activities that enhance the diversity of the biomedical, behavioral and clinical research workforce by providing research experiences and related opportunities that enrich the pool of individuals from nationally underrepresented groups who will be available to compete for research opportunities in the mission areas of importance to NHLBI.

Due Date: 09-20-2018
The over-arching goal of this program is to support educational activities that complement and/or enhance the training of a workforce to meet the nation¿s biomedical, behavioral and clinical research needs. This FOA is intended to support research education activities that enhance the knowledge of substance abuse and addiction research.

Due Date: 10-15-2018
The program is intended to support young investigators of outstanding promise in science relevant to the advancement of human health. The program makes grants to selected academic institutions to support the independent research of outstanding individuals who are in their first few years of their appointment at the assistant professor level.

Commercialization Funding Opportunities

With a 4% Atlanta-based soft drink giant, Coca-Cola, just announced The Bridge, a six-month commercialization program to develop early-stage partnerships.

Due Date: 07-27-2018
The purpose of the award is to provide support to Phase II SBIR or STTR awardees that are developing NHLBI mission-related products that address a rare disease or young pediatric populations. The goal of this FOA is for these products to be further validated so that development can continue with private funding after NHLBI support ends. Applicants must submit a Commercialization Plan that includes details on any independent third-party funding that has already been secured or is anticipated during the project period.

Due Date: 07-27-2018
The purpose of the award is to facilitate and accelerate the capital-intensive steps that are required to transition SBIR/STTR Phase II projects to the commercialization stage by promoting partnerships between SBIR/STTR Phase II awardees and third-party investors and/or strategic partners. Applicants must submit a Commercialization Plan, which should include details on any independent third-party funding that has already been secured or is anticipated during the Phase IIB Bridge Award project period.

Due Date: 06-30-2018
I-Corps South is now offering up to eight $25,000 grants to technology startup teams in the first half of 2018. This unique program is open to any team in the southeast with a strong technology component.

Due Date: 08-15-2018
This FOA solicits Small Business Innovation Research (SBIR) applications from small business concerns that seek additional funding to support the next stage of development for cancer-relevant projects that were previously funded under SBIR or STTR Phase II awards from any Federal agency. The purpose of this FOA is to facilitate the transition of SBIR or STTR Phase II projects to the commercialization stage.

Due Date: 08-15-2018
In celebrating its 350th anniversary, Merck KGaA, Darmstadt, Germany offers a series of research grants to stimulate innovative research in challenging areas of future importance. Merck provides several research grants in various research areas, such as drug discovery, synthetic biology, and computing.

Due Date: 09-05-2018
The National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health invites small businesses to apply for funding through the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR). NCATS encourages applications that address a range of focus areas relevant to any stage of translation, from target validation through pre-clinical and clinical evaluation, to intervention implementation and dissemination, including drug discovery and development; biomedical, clinical, and health research informatics; and clinical, dissemination, and implementation research.

Upcoming Events

    View All Events

    Funding News


    Georgia CTSA Pilot Grants Program

    For over 10 years the Georgia CTSA Pilot Grants program has distributed grant funding to support one to two year pilot projects that advance and transform laboratory, clinic, and community observations into interventions that improve public and...


    Jeff Sands named 91st president of American Physiological Society

    Jeff M. Sands, MD, Juha P. Kokko professor of medicine and physiology, and director of the Division of Renal Medicine in the Department of Medicine, has been named president of the American Physiological Society (APS).